Patent · US Active

Method of protecting against staphylococcal infection

US7754225B2 · kind B2 · utility

5Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2006
Grant dateJul 13, 2010
Priority date
Expiry dateAug 19, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/6037
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate of PS1 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus epidermidis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.